ReviewCurrent nutrition reports2025
Ergogenic Aid by Cordyceps: Does It Work??
Review in Current nutrition reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Cordyceps as a multitarget therapeutic platform: biology, bioactive metabolites, and translational challenges.Archives of microbiology · 2026Review
- Pleiotropic Bioactivity of Caterpillar Fungus, Orange Cordyceps, and Cordycepin: Insight from Integrated Network Pharmacology and Food and Drug Regulatory Framework.Pharmaceuticals (Basel, Switzerland) · 2026Review
- Current Evidence of Ergogenic and Post-Exercise Recovery Effects of Dietary Supplementation withNutrients · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewSupplements for exercise have gained significant attention among athletes and sports practitioners. Herbs with high bioactive content are commonly used to enhance exercise performance. Among these, Cordyceps spp., a traditional herb from China, is recognized for its pharmacological properties, including immunomodulatory, anti-inflammatory, and anti-fibrotic effects observed in vitro. As an immunomodulatory agent, Cordyceps has been shown to successfully stimulate cytokine synthesis in human peripheral blood. Given that inflammation is a natural part of the aerobic exercise response, We aim in this review to summarize the effects of Cordyceps on aerobic performance and fitness in human studies. RECENT
findingsMost studies involved active, young participants. Long-term supplementation with Cordyceps, ranging from 2 to 16 weeks, has demonstrated improvements in aerobic performance in a dose-dependent manner, as evidenced by an increase in time to exhaustion. However, the effects on aerobic fitness remain inconsistent. Furthermore, the ergogenic potential of Cordyceps in aging and sedentary populations requires further investigation due to the limited number of studies available. It also appears that Cordyceps supplementation may have a greater impact on aerobic performance and fitness when combined with other herbs and exercise training. Cordyceps supplementation shows potential as an ergogenic aid for exercise. Further research is needed to explore its effects at the cellular level in human studies.
Indexed as
Identifiers
40768109What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.